期刊文献+

CD4^+CD25^+调节性T细胞在Graves眼病患者外周血中的表达 被引量:5

Detection of CD4^+CD25^+ regulatory T cell in patients with Graves' ophthalmopathy
下载PDF
导出
摘要 目的:通过检测CD4+CD25+调节性T细胞在Graves眼病患者外周血中的表达,以观察该病患者外周血中CD4+CD25+调节性T细胞的变化规律。方法:临床实验研究。采用流式细胞术检测对Graves病不伴有眼征患者组(53例),Graves眼病患者组(51例),正常对照组(51例)的外周静脉血CD4+CD25+Treg细胞比例进行检测。结果:与正常对照组比较,Graves病不伴有眼征患者组Treg水平下降(P<0.01);与正常对照组比较,Graves眼病患者组外周血Treg水平显著下降(P<0.01);Graves眼病患者组外周血Treg数量明显低于Graves病不伴有眼征患者组(P<0.01)。结论:Graves眼病患者外周血中CD4+CD25+Treg在淋巴细胞中所占的比例降低,存在自身免疫调节紊乱。可能是其机体细胞免疫抑制受损的重要机制,为对该疾病进行免疫学治疗提供了新线索。 AIM: To observe the change law of the ratio of CD4* CD25+ regulatory T cell in the peripheral blood of the patients with Graves' ophthalmopathy by detecting the ratio of this cell. ~ METHODS: This experimental study selected 53 GO patients without exophthalmos, 51 GO patients with exophthalmos, and 51 healthy people were collected. The ratio of CD4+ CD25+ T cell in peripheral blood was determined by flow cytometry. ~ RESULTS: The ratio of CD4*CD25+ T cell in GO patients without exophthalmos was lower than that in healthy group (P〈0.01~). The ratio of CD4+CD25~ T cell in GO patients with exophthalmos was far lower than that in healthy group ( P〈0.01 ). Compared with the group of GO patients without exophthalmos, the ratio of CD4~ CD25+ T cell of GO patients with exophthalmos was also much lower ( P〈0.01 ). ~ CONCLUSION : The ratio of CD4+ CD25+ T cell in the GO patients decreases and there is autoimmune disorder in patients of this disease. Perhaps this is an important mechanism causing immune suppression damage, which provides a new clue for immunological treatment.
出处 《国际眼科杂志》 CAS 2013年第11期2188-2191,共4页 International Eye Science
关键词 GRAVES眼病 甲状腺相关性眼病 自身免疫 CD4’CD25’调节性T细胞 Graves' ophthalmopathy thyroid associatedophthalmopathy autoimmune CD4+ CD25~ regulatoryT cell
  • 相关文献

参考文献6

二级参考文献82

  • 1赵永胜,黄铁军,赵丛雯,雷勇,易炜.云克(^(99)Tc-MDP)治疗Graves’眼病19例临床疗效观察[J].齐齐哈尔医学院学报,2004,25(5):483-484. 被引量:4
  • 2高波,熊思东.CD4^+CD25^+调节性T细胞作用机制的双模式[J].生命的化学,2006,26(2):131-133. 被引量:6
  • 3刘家华,徐军发,钟明,周君纯,陈小芳.CD_4^+CD_(25)^+调节性T细胞在免疫性血小板减少性紫癜中的调节作用[J].临床内科杂志,2006,23(6):382-384. 被引量:7
  • 4叶廷军,王佳谊,郭斌.桥本甲状腺炎T细胞的免疫分型及其临床意义[J].第二军医大学学报,2007,28(4):372-376. 被引量:5
  • 5Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299 (5609) : 1057-1061.
  • 6Vukmanovic Stejic M, Zhang Y, Cook JE, et al. Human CD4+ CD25hi Foxp3 regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest, 2006, 116(9): 2423- 2433.
  • 7Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+regulatory T cell. Nat Immunol, 2003, 4(4) :330-336.
  • 8Karakhanova S, Munder M,Schneider M, et al. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J Immunother, 2006, 29(3):336-349.
  • 9Seidel MG, Ernst U, Printz D, et al. Expression of the putatively regulatory T-cell marker FOXP3 by CD4 + CD25 + T cells after pediatric hematopoietic stem cell transplantation, Haematologica, 2006, 91(4) :566-569.
  • 10Liu W, Putnam AL, Xu-Yu Z, et al. CD127expression inversely correlates with Foxp3 and suppressive function of human CD4 + Treg cells. J Exp Med, 2006, 203(7):1701- 1711.

共引文献22

同被引文献56

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部